Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain Tumors

[1]  B. Kunkle,et al.  INCREASED RISK OF CHILDHOOD BRAIN TUMORS AMONG CHILDREN WHOSE PARENTS HAD FARM-RELATED PESTICIDE EXPOSURES DURING PREGNANCY. , 2014, JP journal of biostatistics.

[2]  M. Duchowny,et al.  Bayesian Network and Mechanistic Hierarchical Structure Modeling of Increased likelihood of Developing Intractable Childhood Epilepsy from the Combined Effect of mtDNA Variants, Oxidative Damage, and Copy Number , 2014, Journal of Molecular Neuroscience.

[3]  I. Amelio,et al.  Serine and glycine metabolism in cancer☆ , 2014, Trends in biochemical sciences.

[4]  J. Donoghue,et al.  The regulation of mitochondrial DNA copy number in glioblastoma cells , 2013, Cell Death and Differentiation.

[5]  J. Oliveira,et al.  Lysine deacetylases and mitochondrial dynamics in neurodegeneration. , 2013, Biochimica et biophysica acta.

[6]  Changwon Yoo,et al.  Reverse Engineering of Modified Genes by Bayesian Network Analysis Defines Molecular Determinants Critical to the Development of Glioblastoma , 2013, PloS one.

[7]  Y. Yuasa,et al.  Multiple-to-Multiple Relationships between MicroRNAs and Target Genes in Gastric Cancer , 2013, PloS one.

[8]  K. Blennow,et al.  Cerebrospinal fluid brain injury biomarkers in children: a multicenter study. , 2013, Pediatric neurology.

[9]  F. Scaglia,et al.  Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic Options , 2013, Neurotherapeutics.

[10]  C. Hagel,et al.  Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression , 2013, Journal of Neuro-Oncology.

[11]  Yusuke Nakamura,et al.  Proteomic characterization of ovarian cancers identifying annexin‐A4, phosphoserine aminotransferase, cellular retinoic acid‐binding protein 2, and serpin B5 as histology‐specific biomarkers , 2012, Cancer science.

[12]  P. Jayakar,et al.  Environment, Genetic and Epigenetic Alterations and Pediatric Central Nervous System Tumors , 2011 .

[13]  Q. Felty.  Proteomic 2D DIGE profiling of human vascular endothelial cells exposed to environmentally relevant concentration of endocrine disruptor PCB153 and physiological concentration of 17β-estradiol , 2011, Cell Biology and Toxicology.

[14]  H. Christian,et al.  Annexin A1: A Central Player in the Anti-Inflammatory and Neuroprotective Role of Microglia , 2010, The Journal of Immunology.

[15]  Pascale Varlet,et al.  Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas. , 2010, Neuro-oncology.

[16]  B. Kleinschmidt-DeMasters,et al.  Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma , 2009, Brain pathology.

[17]  P. Jayakar,et al.  Gene–Environment Interaction and Susceptibility to Pediatric Brain Tumors , 2010 .

[18]  D. Roy,et al.  Environmental Factors, Genes, and the Development of Human Cancers , 2010 .

[19]  C. Ambrosone,et al.  Mitochondrial copy number and risk of breast cancer: a pilot study. , 2010, Mitochondrion.

[20]  Keshav K. Singh,et al.  Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion , 2008, Cancer biology & therapy.

[21]  D. Smiraglia,et al.  A novel role for mitochondria in regulating epigenetic modifications in the nucleus , 2008, Cancer biology & therapy.

[22]  V. Denis,et al.  Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells , 2008, Molecular Cancer.

[23]  S. Leal,et al.  Mitochondrial genetic background modifies breast cancer risk. , 2007, Cancer research.

[24]  G. Matthijs,et al.  Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway. , 2007, American journal of human genetics.

[25]  P. Jayakar,et al.  Signature of mitochondria of steroidal hormones-dependent normal and cancer cells: potential molecular targets for cancer therapy. , 2007, Frontiers in bioscience : a journal and virtual library.

[26]  S. Ohta,et al.  Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs , 2006, Oncogene.

[27]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[28]  R. Nishigaki,et al.  Evidence for a role of Collapsin response mediator protein-2 in signaling pathways that regulate the proliferation of non-neuronal cells. , 2006, Biochemical and biophysical research communications.

[29]  M. Kiebish,et al.  Absence of pathogenic mitochondrial DNA mutations in mouse brain tumors , 2005, BMC Cancer.

[30]  Yau-Huei Wei,et al.  Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. , 2005, The international journal of biochemistry & cell biology.

[31]  E. Leshinsky‐Silver,et al.  White matter involvement in mitochondrial diseases. , 2005, Molecular genetics and metabolism.

[32]  D. Roy,et al.  Estrogen, mitochondria, and growth of cancer and non-cancer cells , 2005, Journal of carcinogenesis.

[33]  V. Bezlepkin,et al.  The increase in mitochondrial DNA copy number in the tissues of gamma-irradiated mice. , 2005, Cellular & molecular biology letters.

[34]  V. Bezlepkin,et al.  THE INCREASE IN MITOCHONDRIAL DNA COPY NUMBER IN THE TISSUES OF Γ-IRRADIATED MICE , 2005 .

[35]  G. Broggi,et al.  Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas , 2005, Journal of Neuro-Oncology.

[36]  C. Daumas-Duport,et al.  New Variants of Malignant Glioneuronal Tumors: A Clinicopathological Study of 40 Cases , 2004, Neurosurgery.

[37]  I. Silver,et al.  Energy metabolism in mammalian brain during development , 2004, Progress in Neurobiology.

[38]  R. Martuza,et al.  Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. , 2004, Molecular cancer research : MCR.

[39]  I. Chang,et al.  Resistance of Mitochondrial DNA-depleted Cells against Cell Death , 2004, Journal of Biological Chemistry.

[40]  Á. Carracedo,et al.  mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations , 2004, Oncogene.

[41]  F. Davis,et al.  The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States , 1999, Cancer Causes & Control.

[42]  J. Rodrigo,et al.  Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. , 2004, The American journal of pathology.

[43]  N P Burrows,et al.  Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. , 2003, Human molecular genetics.

[44]  J. Modica-Napolitano,et al.  Mitochondria as targets for detection and treatment of cancer , 2002, Expert Reviews in Molecular Medicine.

[45]  P. Rustin.  Mitochondria, from cell death to proliferation , 2002, Nature Genetics.

[46]  S. Weis,et al.  High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples , 2001, International journal of cancer.

[47]  E S Husebye,et al.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.

[48]  G. Buonocore,et al.  Free Radicals and Brain Damage in the Newborn , 2001, Neonatology.

[49]  J. Rosenblatt,et al.  Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction. , 2000, Methods.

[50]  H. C. Lee,et al.  Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. , 2000, The Biochemical journal.

[51]  R. Schneider-Stock,et al.  Loss of heteroplasmy in the displacement loop of brain mitochondrial DNA in astrocytic tumors , 1999, Genes, chromosomes & cancer.

[52]  N. Larsson,et al.  Revolution in mitochondrial medicine , 1999, FEBS letters.

[53]  I. Nelson,et al.  Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA. , 1998, American journal of human genetics.

[54]  F. Gilles,et al.  Co-expression of four intermediate filament subclasses in childhood glial neoplasms. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[55]  R. Criddle,et al.  Investigation of the structural arrangement of the protein subunits of mitochondrial ATPase. , 1977, Archives of biochemistry and biophysics.